Clinical significance, tumor immune landscape and immunotherapy responses of ADAR in pan-cancer and its association with proliferation and metastasis of bladder cancer

Abstract

INTRODUCTIONAfter decades of unremitting efforts by medical scientists, great progress has been made in cancer treatment strategies and clinical outcomes. However, many patients remain stranded in the shadow of drug resistance, disease progression, relapse, and eventual death [1]. Among a variety of treatment modalities, antitumor immunotherapy has received sufficient attention in recent years and has achieved considerable www.aging-us.com